X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10337) 10337
Book Review (1223) 1223
Publication (783) 783
Conference Proceeding (66) 66
Dissertation (35) 35
Book Chapter (32) 32
Web Resource (3) 3
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxaliplatin (9128) 9128
index medicus (7233) 7233
humans (6342) 6342
oncology (5579) 5579
chemotherapy (4694) 4694
male (4042) 4042
female (3952) 3952
middle aged (3490) 3490
cancer (3443) 3443
aged (3371) 3371
colorectal cancer (3244) 3244
fluorouracil (2792) 2792
antineoplastic combined chemotherapy protocols - therapeutic use (2709) 2709
adult (2619) 2619
leucovorin (2197) 2197
colorectal neoplasms - drug therapy (2183) 2183
organoplatinum compounds - administration & dosage (2000) 2000
treatment outcome (1935) 1935
colorectal neoplasms - pathology (1810) 1810
irinotecan (1767) 1767
fluorouracil - administration & dosage (1624) 1624
metastasis (1488) 1488
cisplatin (1478) 1478
5-fluorouracil (1435) 1435
surgery (1424) 1424
capecitabine (1394) 1394
survival (1385) 1385
antineoplastic combined chemotherapy protocols - adverse effects (1338) 1338
care and treatment (1338) 1338
1st-line treatment (1332) 1332
bevacizumab (1291) 1291
aged, 80 and over (1278) 1278
pharmacology & pharmacy (1252) 1252
therapy (1128) 1128
trial (1107) 1107
disease-free survival (1091) 1091
organoplatinum compounds - adverse effects (1063) 1063
medicine & public health (1061) 1061
prognosis (1028) 1028
neoplasm staging (1010) 1010
analysis (984) 984
leucovorin - administration & dosage (981) 981
deoxycytidine - analogs & derivatives (970) 970
research (966) 966
antineoplastic agents - therapeutic use (960) 960
camptothecin - analogs & derivatives (954) 954
retrospective studies (930) 930
antineoplastic combined chemotherapy protocols - administration & dosage (929) 929
animals (893) 893
combination (889) 889
organoplatinum compounds - therapeutic use (855) 855
liver neoplasms - secondary (852) 852
carcinoma (815) 815
cetuximab (803) 803
survival rate (788) 788
antineoplastic agents (782) 782
colorectal-cancer (773) 773
cancer therapies (762) 762
patients (756) 756
tumors (733) 733
neoplasm metastasis (732) 732
gemcitabine (730) 730
drug therapy (725) 725
antimitotic agents (724) 724
deoxycytidine - administration & dosage (719) 719
antineoplastic agents - adverse effects (708) 708
camptothecin - administration & dosage (697) 697
liver neoplasms - drug therapy (681) 681
adenocarcinoma - drug therapy (680) 680
fluorouracil - therapeutic use (670) 670
phase-ii (668) 668
metastatic colorectal-cancer (667) 667
clinical trials (660) 660
fluorouracil - adverse effects (656) 656
colon cancer (653) 653
health aspects (635) 635
survival analysis (633) 633
colorectal neoplasms - mortality (628) 628
antineoplastic agents - administration & dosage (609) 609
antineoplastic agents - pharmacology (600) 600
chemotherapy, adjuvant (599) 599
colon-cancer (593) 593
gastroenterology & hepatology (588) 588
hematology, oncology and palliative medicine (587) 587
cell line, tumor (585) 585
organoplatinum compounds - pharmacology (571) 571
apoptosis (567) 567
fluorouracil - analogs & derivatives (566) 566
toxicity (560) 560
folinic acid (558) 558
adenocarcinoma (557) 557
drug administration schedule (557) 557
metastases (549) 549
colorectal carcinoma (545) 545
phase-iii trial (536) 536
cancer research (532) 532
adjuvant chemotherapy (516) 516
randomized-trial (503) 503
gastric cancer (499) 499
cancer patients (484) 484
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9920) 9920
French (175) 175
German (134) 134
Japanese (56) 56
Chinese (37) 37
Korean (36) 36
Spanish (32) 32
Italian (16) 16
Russian (9) 9
Polish (7) 7
Czech (6) 6
Hungarian (2) 2
Portuguese (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALS OF SURGERY, ISSN 0003-4932, 08/2019, Volume 270, Issue 2, pp. E39 - E40
Journal Article
04/2012
Background: Oxaliplatin has shown promising activity in metastatic gastric cancer (MGC) and has synergism with 5 fluorouracil. This phase II study was... 
Chemotherapy | gastric | oxaliplatin
Web Resource
CANCER SCIENCE, ISSN 1347-9032, 08/2015, Volume 106, Issue 8, pp. 1101 - 1102
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 9/2018, Volume 35, Issue 9, pp. 1 - 17
Colon adenocarcinoma is the most common form of gastro intestinal tract cancer, predominantly in ageing population. Chemotherapy with 5-Fluorouracil and... 
Biochemistry, general | Biomedical Engineering | 5-fluorouracil | colon ACF | Biomedicine | colon adenocarcinoma | pharmacokinetic parameters | Pharmacy | Medical Law | lactoferrin nanoparticles | oxaliplatin | Pharmacology/Toxicology | IMPROVE | CELLS | CHEMOTHERAPEUTIC DRUGS | CANCER | CHEMISTRY, MULTIDISCIPLINARY | PHARMACOKINETICS | THERAPEUTIC-EFFICACY | RESISTANCE | PHARMACOLOGY & PHARMACY | EXPRESSION | TARGETED DELIVERY | BRAIN DELIVERY | Adenocarcinoma - pathology | Nanoparticles - chemistry | Rats, Wistar | Colonic Neoplasms - drug therapy | Humans | Oxaliplatin - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Oxaliplatin - adverse effects | Colonic Neoplasms - metabolism | Drug Carriers - chemistry | Oxaliplatin - pharmacokinetics | Tissue Distribution | Fluorouracil - therapeutic use | Adenocarcinoma - metabolism | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Antineoplastic Agents - pharmacokinetics | Oxaliplatin - administration & dosage | Nanoparticles - ultrastructure | Adenocarcinoma - drug therapy | Lactoferrin - chemistry | Animals | Colonic Neoplasms - pathology | Cell Line, Tumor | Cell Proliferation - drug effects | Fluorouracil - pharmacokinetics | Adenocarcinoma | Drugs | Drug delivery systems | Lactoferrins | Petroleum | Vehicles | Nanoparticles | Chemotherapy | Colon cancer | Refining | Analysis | Fluorouracil | Cancer | Evaluation | Effectiveness | Parameters | 5-Fluorouracil | Toxicity | Rats | Pharmacology | Drug delivery | Lactoferrin | Oxaliplatin | Intestine | Cell lines | Aging | Biocompatibility | In vivo methods and tests | Safety | Colon | Pharmacokinetics | Index Medicus
Journal Article
Neuroscience Letters, ISSN 0304-3940, 09/2019, Volume 709, pp. 134378 - 134378
Oxaliplatin is a third-generation platinum drug commonly used as the first line treatment of metastatic colorectal cancer. Oxaliplatin-based anticancer... 
Neurotoxicity | Oxaliplatin | Metformin | Index Medicus
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2019, Volume 153, pp. 111 - 120
Oxaliplatin is a third-generation derivative of platinum that is effective in the treatment of multiple solid tumors. However, it can cause peripheral... 
Nav1.6 | miR-30b | Oxaliplatin | Neuropathic pain
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2019, Volume 42, Issue 6, pp. 900 - 905
The present study aims to investigate the effects of ginsenoside Rg3 combined with oxaliplatin on the proliferation and apoptosis of hepatocellular carcinoma... 
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2018, Volume 110, Issue 8, pp. 888 - 894
Background: Oxaliplatin-based chemotherapy can cause hepatic sinusoidal injury (HSI), portal hypertension, and splenic sequestration of platelets. Evidence... 
PATHOGENESIS | PREOPERATIVE CHEMOTHERAPY | PLUS OXALIPLATIN | ONCOLOGY | OBSTRUCTION SYNDROME | ADJUVANT TREATMENT | COLORECTAL LIVER METASTASES | COMBINATION | FLUOROURACIL | CANCER | DOSE INTENSITY | Thrombocytopenia - epidemiology | Liver - pathology | Bevacizumab - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Spleen - drug effects | Oxaliplatin - adverse effects | Clinical Trials, Phase III as Topic | Neoplasm Metastasis | Leucovorin - adverse effects | Multicenter Studies as Topic | Fluorouracil - adverse effects | Liver - drug effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Oxaliplatin - administration & dosage | Retrospective Studies | Spleen - pathology | Colorectal Neoplasms - epidemiology | Bevacizumab - administration & dosage | Chemical and Drug Induced Liver Injury - epidemiology | Thrombocytopenia - chemically induced | Randomized Controlled Trials as Topic | Organ Size - drug effects | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - adverse effects | Index Medicus | Liver | Organoplatinum Compounds | Leucovorin | Bevacizumab | Life Sciences | Oxaliplatin | Colorectal Neoplasms | Fluorouracil | Spleen | Thrombocytopenia | Organ Size | Antineoplastic Combined Chemotherapy Protocols | Human health and pathology | Chemical and Drug Induced Liver Injury | Cancer
Journal Article
06/2011
Mangiferin-mediated down-regulation of NFκB showed potential for chemotherapeutic agent-mediated cell death, suggesting a role in combination therapy for... 
Combination treatment | Oxaliplatin | Drug resistance | Mangiferin | Apoptosis
Web Resource
06/2011
The present study determined the anti-inflammatory activity of Wissadula amplissima var rostrata (Schum. & Thonn.), and calculated the total phenolic content... 
Combination treatment | Oxaliplatin | Drug resistance | Mangiferin | Apoptosis
Web Resource
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2018, Volume 81, Issue 1, pp. 155 - 161
Journal Article